not tagged
not tagged
['mds']
eha2022 ends with a bang! immunotherapy in b-cell disease, a call to action on increasing access to new therapies for the majority of sickle patients, &amp; the ipss-m finally lands with improved risk stratification for half of mds patients. #mds #eha2022 